These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. Yokel RA J Alzheimers Dis; 2006 Nov; 10(2-3):223-53. PubMed ID: 17119290 [TBL] [Abstract][Full Text] [Related]
24. Decreased serum ferritin may be associated with increased restless legs syndrome in Parkinson's disease (PD): a meta-analysis for the diagnosis of RLS in PD patients. Li K; Liu B; Wang F; Bao J; Wu C; Huang X; Hu F; Xu Z; Ren H; Yang X Int J Neurosci; 2019 Oct; 129(10):995-1003. PubMed ID: 31092087 [No Abstract] [Full Text] [Related]
25. Association between serum hepcidin level and restless legs syndrome. Dauvilliers Y; Chenini S; Vialaret J; Delaby C; Guiraud L; Gabelle A; Lopez R; Hirtz C; Jaussent I; Lehmann S Mov Disord; 2018 Apr; 33(4):618-627. PubMed ID: 29418021 [TBL] [Abstract][Full Text] [Related]
26. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Connor JR; Boyer PJ; Menzies SL; Dellinger B; Allen RP; Ondo WG; Earley CJ Neurology; 2003 Aug; 61(3):304-9. PubMed ID: 12913188 [TBL] [Abstract][Full Text] [Related]
27. Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: a nation-wide study. Shin HY; Youn J; Yoon WT; Kim JS; Cho JW Parkinsonism Relat Disord; 2013 Mar; 19(3):355-8. PubMed ID: 23047004 [TBL] [Abstract][Full Text] [Related]
28. Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases. Gao G; Chang YZ Front Pharmacol; 2014; 5():19. PubMed ID: 24596558 [TBL] [Abstract][Full Text] [Related]
29. Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Piao YS; Lian TH; Hu Y; Zuo LJ; Guo P; Yu SY; Liu L; Jin Z; Zhao H; Li LX; Yu QJ; Wang RD; Chen SD; Chan P; Wang XM; Zhang W Sci Rep; 2017 Sep; 7(1):10547. PubMed ID: 28874701 [TBL] [Abstract][Full Text] [Related]
30. Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease. Rana AQ; Qureshi AR; Rahman L; Jesudasan A; Hafez KK; Rana MA Int J Neurosci; 2016; 126(2):116-20. PubMed ID: 25469455 [TBL] [Abstract][Full Text] [Related]
31. Bayesian inference for parameter estimation in lactoferrin-mediated iron transport across blood-brain barrier. Khan AI; Liu J; Dutta P Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129459. PubMed ID: 31682896 [TBL] [Abstract][Full Text] [Related]
32. Are serum ferritin and transferrin saturation risk markers for restless legs syndrome in young adults? Longitudinal and cross-sectional data from the Western Australian Pregnancy Cohort (Raine) Study. Lammers N; Curry-Hyde A; Smith AJ; Eastwood PR; Straker LM; Champion D; McArdle N J Sleep Res; 2019 Oct; 28(5):e12741. PubMed ID: 30062860 [TBL] [Abstract][Full Text] [Related]
33. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679 [TBL] [Abstract][Full Text] [Related]
34. Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome. Haschka D; Volani C; Stefani A; Tymoszuk P; Mitterling T; Holzknecht E; Heidbreder A; Coassin S; Sumbalova Z; Seifert M; Dichtl S; Theurl I; Gnaiger E; Kronenberg F; Frauscher B; Högl B; Weiss G Mov Disord; 2019 Jan; 34(1):114-123. PubMed ID: 30311259 [TBL] [Abstract][Full Text] [Related]
35. Transferrin and transferrin receptor function in brain barrier systems. Moos T; Morgan EH Cell Mol Neurobiol; 2000 Feb; 20(1):77-95. PubMed ID: 10690503 [TBL] [Abstract][Full Text] [Related]
36. Brain iron uptake and homeostatic mechanisms: an overview. Burdo JR; Connor JR Biometals; 2003 Mar; 16(1):63-75. PubMed ID: 12572665 [TBL] [Abstract][Full Text] [Related]
37. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. Connor JR; Snyder BS; Beard JL; Fine RE; Mufson EJ J Neurosci Res; 1992 Feb; 31(2):327-35. PubMed ID: 1573683 [TBL] [Abstract][Full Text] [Related]
38. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Burdo JR; Antonetti DA; Wolpert EB; Connor JR Neuroscience; 2003; 121(4):883-90. PubMed ID: 14580938 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]